Eyal Shapira

Original Research

A Novel Recombinant Human Collagen-based Flowable Matrix for Chronic Lower Limb Wound Management: First Results of a Clinical Trial

04/01/2019

Itay Wiser

Eran Tamir

Hanna Kaufman

Elad Keren

Shalom Avshalom

Doron Klein

Lior Heller

Eyal Shapira

This study aims to assess the safety and performance of a novel flowable wound matrix, formulated from tobacco plant-purified fibrillated recombinant human type I collagen (rhCollagen), in patients with chronic lower limb ulcers.

This study aims to assess the...

04/01/2019

Wounds

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

July 18 ⁠–⁠ July 19

July 19 ⁠–⁠ July 20

July 24 ⁠–⁠ July 26

July 26 ⁠–⁠ July 27

July 27 ⁠–⁠ July 28

August 8 ⁠–⁠ August 9

August 14 ⁠–⁠ August 17

August 16 ⁠–⁠ August 17

August 16 ⁠–⁠ August 18

See Full Calendar

Eyal Shapira

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products